Goldman Sachs’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $288K | Sell |
223,450
-141,753
| -39% | -$234K | ﹤0.01% | 5912 |
|
|
2025
Q4 | $807K | Sell |
365,203
-29,687
| -8% | -$55.8K | ﹤0.01% | 5279 |
|
|
2025
Q3 | $640K | Buy |
394,890
+184,413
| +88% | +$386K | ﹤0.01% | 5346 |
|
|
2025
Q2 | $545K | Buy |
210,477
+13,978
| +7% | +$55.1K | ﹤0.01% | 5109 |
|
|
2025
Q1 | $1.32M | Sell |
196,499
-47,048
| -19% | -$333K | ﹤0.01% | 4485 |
|
|
2024
Q4 | $1.65M | Sell |
243,547
-10,209
| -4% | -$67.2K | ﹤0.01% | 4449 |
|
|
2024
Q3 | $2.1M | Buy |
253,756
+11,837
| +5% | +$85.7K | ﹤0.01% | 4111 |
|
|
2024
Q2 | $1.53M | Buy |
241,919
+27,307
| +13% | +$210K | ﹤0.01% | 4134 |
|
|
2024
Q1 | $1.99M | Sell |
214,612
-37,802
| -15% | -$443K | ﹤0.01% | 3868 |
|
|
2023
Q4 | $3.22M | Buy |
252,414
+140,119
| +125% | +$1.46M | ﹤0.01% | 3547 |
|
|
2023
Q3 | $1.16M | Sell |
112,295
-111,681
| -50% | -$1.29M | ﹤0.01% | 4167 |
|
|
2023
Q2 | $2.94M | Buy |
223,976
+71,946
| +47% | +$880K | ﹤0.01% | 3572 |
|
|
2023
Q1 | $1.7M | Sell |
152,030
-189,494
| -55% | -$1.87M | ﹤0.01% | 3986 |
|
|
2022
Q4 | $2.88M | Sell |
341,524
-333,210
| -49% | -$3.17M | ﹤0.01% | 3646 |
|
|
2022
Q3 | $11.2M | Buy |
674,734
+233,630
| +53% | +$4.3M | ﹤0.01% | 2396 |
|
|
2022
Q2 | $6.49M | Sell |
441,104
-59,918
| -12% | -$1.23M | ﹤0.01% | 2898 |
|
|
2022
Q1 | $12.4M | Buy |
501,022
+395,566
| +375% | +$10.2M | ﹤0.01% | 2469 |
|
|
2021
Q4 | $3.38M | Sell |
105,456
-48,248
| -31% | -$1.76M | ﹤0.01% | 3784 |
|
|
2021
Q3 | $5.53M | Buy |
153,704
+59,624
| +63% | +$2.35M | ﹤0.01% | 3279 |
|
|
2021
Q2 | $4.15M | Buy |
+94,080
| New | +$4.1M | ﹤0.01% | 3508 |
|
|
2021
Q1 | – | Sell |
-29,118
| Closed | -$2.01M | – | 6230 |
|
|
2020
Q4 | $2.01M | Buy |
+29,118
| New | +$1.43M | ﹤0.01% | 3728 |
|
Other funds holding LUNG
SCM
ECM
VCM
